|
Workshops On Viral Oncogenesis and Pathogenesis
|
5R13CA095919-12
|
$5,000
|
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Web-Assisted Tobacco Intervention with Community College Students
|
5R01CA152093-04
|
$515,606
|
|
MCINTOSH, SCOTT
|
UNIVERSITY OF ROCHESTER
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
5R01CA044722-24
|
$216,873
|
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
Vermont PROSPR Research Center (VPRC)
|
5U54CA163303-04
|
$1,167,472
|
|
SPRAGUE, BRIAN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-14
|
$1,007,108
|
|
HANDE, KENNETH
|
VANDERBILT UNIVERSITY
|
|
Utilizing HuR to optimize the treatment of pancreatic cancer
|
1R21CA182692-01A1
|
$202,275
|
|
BRODY, JONATHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Using medical informatics to follow-up a colorectal sessile serrated polyp cohort
|
1R03CA186215-01
|
$88,000
|
|
BURNETT-HARTMAN, ANDREA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using 3d bioprinting for Nipple Areola Complex (NAC) reconstruction
|
1R43CA186666-01
|
$150,000
|
|
COLLINS, SCOTT
|
TEVIDO BIODEVICES, LLC
|
|
UCSD Cancer Nanotechnology Training Center
|
5R25CA153915-05
|
$328,016
|
|
MATTREY, ROBERT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Tyrosine kinase inhibition and immunomodulation for cancer
|
1F32CA186534-01
|
$53,282
|
|
ZHANG, JENNIFER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Tumorigenic Role of the CUL4A Ubiquitin Ligase
|
5R01CA159925-04
|
$393,337
|
|
ZHOU, PENGBO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer
|
5U01CA151461-05
|
$417,627
|
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC)
|
2R01CA121275-06A1
|
$346,219
|
|
LEONE, GUSTAVO
|
OHIO STATE UNIVERSITY
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$379,286
|
$303,429
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCER
|
5R01CA155578-04
|
$668,484
|
|
TAYLOR, KATHRYN
|
GEORGETOWN UNIVERSITY
|
|
Translating Research into Systemic Interventions for Tobacco Cessation
|
5K07CA140236-04
|
$169,560
|
|
APOLLONIO, DOROTHY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Transduction of T cells to improve migration to tumor
|
5R01CA116206-10
|
$264,095
|
|
HWU, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Transcription-dependent and -independent signaling of RSK2 in cancer metastasis
|
1R01CA175316-01A1
|
$323,700
|
|
KANG, SUMIN
|
EMORY UNIVERSITY
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-26
|
$2,148,164
|
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-05
|
$313,570
|
|
ANDERSON, BRADLEY
|
UNIVERSITY OF KENTUCKY
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
5R01CA137019-05
|
$282,481
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Type III TGF-beta Receptor in the Fibrotic Tumor Stroma
|
5F31CA180602-02
|
$32,882
|
|
HESLER, RACHEL
|
DUKE UNIVERSITY
|
|
The role of HDAC2 in hormone therapy resistance
|
5R01CA152989-04
|
$310,970
|
|
MUNSTER, PAMELA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$192,605
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S1
|
$250,000
|
$7,500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
$6,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
$7,385
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S4
|
$58,383
|
$1,751
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Genetics and Prevention of Gastrointestinal Cancers
|
5K24CA113433-10
|
$196,620
|
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INST
|
|
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors
|
1K08CA179084-01A1
|
$115,125
|
|
YANG, SUN
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Temperature monitoring in moving organs during thermal ablation
|
5R01CA149342-04
|
$378,944
|
|
MADORE, BRUNO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Telephone Symptom Management for Advanced Lung Cancer Patients and Caregivers
|
5K07CA168883-02
|
$136,445
|
|
MOSHER, CATHERINE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
TCR Gene Transfer for Treating HCV-Associated Malignancies
|
1F30CA180731-01A1
|
$29,498
|
|
SPEAR, TIMOTHY
|
LOYOLA UNIVERSITY CHICAGO
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$119
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
|
1R01CA174808-01A1
|
$326,348
|
|
SHOHET, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles
|
5U01CA151837-05
|
$417,323
|
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5R00CA139009-05
|
$241,530
|
|
ITO, KEISUKE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
|
1U01CA178960-01A1
|
$526,166
|
|
DWINELL, MICHAEL
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Targeting Oncogene Expression to Skin in Transgenic Mice
|
5R01CA052607-22
|
$462,072
|
|
ROOP, DENNIS
|
UNIVERSITY OF COLORADO DENVER
|
|
Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer
|
5R01CA163649-03
|
$403,980
|
|
SINGH, PANKAJ
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
|
5P01CA163200-03
|
$1,237,917
|
|
EIBL, GUIDO
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Targeting aggressive prostate cancer with novel theranostic nanomedicine
|
5R01CA159144-04
|
$314,875
|
|
HSIEH, JER-TSONG
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Targeted-and Image-Based Adenovirus Cancer Therapeutic Vectors
|
5R01CA154697-04
|
$460,508
|
|
CURIEL, DAVID
|
WASHINGTON UNIVERSITY
|
|
Targeted Transcatheter Magneto-Mechanical Therapy for Hepatocellular Carcinoma
|
5R21CA173491-02
|
$195,574
|
|
KIM, DONG-HYUN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeted Therapy of Triple Negative Breast Cancer Using Theranostic Nanoparticles
|
5R01CA154129-04
|
$312,222
|
|
YANG, LILY
|
EMORY UNIVERSITY
|
|
Targeted Therapy of Neuroendocrine Cancers Via the Notch Signaling Pathway
|
5K25CA166178-02
|
$198,720
|
|
GONG, SHAOQIN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Targeted Erythrocyte Membrane-Coated Nanoparticles for the Treatment of AML
|
1F31CA186392-01
|
$34,342
|
|
LUK, BRIAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Targeted Delivery of Nanodiamonds for Breast Cancer Imaging and Therapy
|
5F30CA174156-02
|
$47,676
|
|
MOORE, LAURA
|
NORTHWESTERN UNIVERSITY
|
|
Tailored Touchscreen Colorectal Cancer Prevention in American Indian Communities
|
5R01CA158238-04
|
$504,749
|
|
GREINER, K
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Susceptibility Markers for a Breast-Colon Cancer Phenotype
|
5K07CA160753-03
|
$120,528
|
|
PANDE, MALA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Contraception and Reproduction Research for this search: $4,233,023
|